skip nav
  Home | About CDC | Press Room | A-Z Index | Contact Us
spacer
CDC Centers for Disease Control and Prevention Home Page
CDC en Español
Search:  
CDC Home > HIV/AIDS > Topics > Statistics and Surveillance > Reports > Cases of HIV Infection and AIDS in the United States and Dependent Areas, by Race/Ethnicity, 2002–2006
spacer
spacer spacer
spacer
 
Skip Nav spacer
spacer
Table 4. Estimated numbers of AIDS cases, by race/ethnicity and transmission category, 2002–2006 and cumulative—United States and dependent areas
spacer
spacer
View PDF PDF icon
Transmission category Year of diagnosis Cumulative through 2006a
2002 2003 2004 2005 2006
  White
Male adult or adolescent            
Male-to-male sexual contact 6,826 6,761 6,862 6,612 6,691 267,805
Injection drug use 1,116 1,108 998 996 1,020 35,086
Male-to-male sexual contact and injection drug use 855 811 780 825 750 32,968
High-risk heterosexual contactb 648 641 654 652 776 10,635
Otherc 90 61 81 67 70 7,809
Subtotal 9,534 9,382 9,374 9,152 9,307 354,302
Female adult or adolescent            
Injection drug use 659 570 629 577 561 16,586
High-risk heterosexual contactb 1,010 980 1,051 950 1,075 19,638
Otherc 33 33 35 32 31 2,311
Subtotal 1,701 1,582 1,715 1,559 1,667 38,535
Total adults and adolescents 11,235 10,964 11,090 10,711 10,974 392,838
Child (<13 yrs at diagnosis)            
Perinatal 14 12 7 4 4 1,241
Otherd 0 0 0 0 0 359
Subtotal 14 12 7 4 4 1,600
Total 11,250 10,976 11,097 10,715 10,978 394,438
  Black/African American
Male adult or adolescent            
Male-to-male sexual contact 5,560 5,747 5,717 5,597 5,714 122,139
Injection drug use 3,122 2,984 2,715 2,490 2,322 94,450
Male-to-male sexual contact and injection drug use 837 806 758 750 678 24,727
High-risk heterosexual contactb 2,958 2,875 2,944 2,755 2,822 41,803
Otherc 113 114 103 113 97 4,356
Subtotal 12,591 12,526 12,237 11,705 11,633 287,474
Female adult or adolescent            
Injection drug use 1,806 1,759 1,706 1,563 1,404 45,287
High-risk heterosexual contactb 4,709 5,118 4,921 4,756 4,903 69,364
Otherc 128 141 147 128 138 3,258
Subtotal 6,643 7,019 6,773 6,446 6,446 117,909
Total adults and adolescents 19,234 19,545 19,010 18,151 18,079 405,383
Child (<13 yrs at diagnosis)            
Perinatal 71 45 34 39 29 5,531
Otherd 1 0 0 0 0 143
Subtotal 72 46 34 39 30 5,675
Total 19,307 19,590 19,044 18,191 18,109 411,058
  Hispanic/Latinoe
Male adult or adolescent            
Male-to-male sexual contact 3,091 3,309 3,272 3,277 3,337 72,900
Injection drug use 1,500 1,434 1,306 1,340 1,211 50,955
Male-to-male sexual contact and injection drug use 373 405 366 333 357 11,973
High-risk heterosexual contactb 1,000 1,064 994 977 1,001 15,044
Otherc 45 44 46 52 51 1,593
Subtotal 6,009 6,257 5,985 5,978 5,957 152,464
Female adult or adolescent            
Injection drug use 462 523 490 462 439 14,555
High-risk heterosexual contactb 1,215 1,309 1,165 1,290 1,281 22,065
Otherc 38 40 32 39 52 968
Subtotal 1,715 1,873 1,687 1,791 1,771 37,589
Total adults and adolescents 7,725 8,131 7,671 7,770 7,728 190,053
Child (<13 yrs at diagnosis)            
Perinatal 22 12 10 8 3 2,019
Otherd 1 0 0 0 0 137
Subtotal 23 12 10 8 3 2,157
Total 7,748 8,143 7,682 7,778 7,732 192,209
  Asian
Male adult or adolescent            
Male-to-male sexual contact 206 218 215 200 242 4,622
Injection drug use 30 38 33 36 42 543
Male-to-male sexual contact and injection drug use 19 12 16 19 20 325
High-risk heterosexual contactb 60 46 47 49 55 583
Otherc 5 6 4 4 4 210
Subtotal 320 320 315 308 365 6,282
Female adult or adolescent            
Injection drug use 9 10 14 12 13 171
High-risk heterosexual contactb 52 59 57 60 65 732
Otherc 5 4 3 4 4 114
Subtotal 66 72 74 76 82 1,017
Total adults and adolescents 386 393 389 384 446 7,299
Child (<13 yrs at diagnosis)            
Perinatal 0 0 0 1 1 33
Otherd 0 0 0 0 0 14
Subtotal 0 0 0 1 1 47
Totalf 386 393 389 385 448 7,346
  American Indian/Alaska Native
Male adult or adolescent            
Male-to-male sexual contact 80 76 65 75 63 1,511
Injection drug use 25 22 21 21 21 437
Male-to-male sexual contact and injection drug use 17 17 22 23 17 474
High-risk heterosexual contactb 7 14 14 14 17 164
Otherc 1 2 0 0 0 41
Subtotal 130 132 122 133 118 2,627
Female adult or adolescent            
Injection drug use 19 19 22 16 17 306
High-risk heterosexual contactb 27 24 35 21 19 354
Otherc 1 1 1 1 1 28
Subtotal 47 44 59 39 37 688
Total adults and adolescents 176 176 181 171 155 3,315
Child (<13 yrs at diagnosis)            
Perinatal 1 1 1 0 0 31
Otherd 0 0 0 0 0 1
Subtotal 1 1 1 0 0 32
Total 177 177 182 171 155 3,347
  Native Hawaiian/Other Pacific Islander
Male adult or adolescent            
Male-to-male sexual contact 25 34 28 38 38 423
Injection drug use 0 1 1 1 6 34
Male-to-male sexual contact and injection drug use 2 4 6 1 1 29
High-risk heterosexual contactb 1 5 6 8 6 38
Otherc 0 0 0 0 0 9
Subtotal 29 44 42 48 51 532
Female adult or adolescent            
Injection drug use 0 3 1 3 3 24
High-risk heterosexual contactb 6 7 11 10 10 78
Otherc 1 0 0 0 0 6
Subtotal 7 10 12 13 13 108
Total adults and adolescents 36 54 54 61 64 640
Child (<13 yrs at diagnosis)            
Perinatal 1 0 1 0 0 7
Otherd 0 0 0 0 0 0
Subtotal 1 0 1 0 0 7
Total 37 54 55 61 64 647
Total casesg 39,250 39,690 38,807 37,662 37,852 1,014,797
Note. These numbers do not represent reported case counts. Rather, these numbers are point estimates, which result from adjustments of reported case counts. The reported case counts have been adjusted for reporting delays and for redistribution of cases in persons initially reported without an identified risk factor, but not for incomplete reporting.
a From the beginning of the epidemic through 2006.
b Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
c Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
d Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
e Hispanics or Latinos can be of any race.
f Includes Asian and Pacific Islander legacy cases (see Technical Notes).
g Includes persons of unknown race or multiple races and persons of unknown sex. Because column totals were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.

Next: Table 5

Last Modified: September 18, 2008
Last Reviewed: September 18, 2008
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

 
spacer
spacer
spacer
spacer
  Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov.		 spacer USA.gov: The U.S. Government's Official Web PortalDHHS Department of Health
and Human Services